Cannabis, THC, CBD & Hemp Regulations in Africa: Complete 2026 Guide
Research date: 26 September 2026
This overview is based on primary legislation, government gazettes, official statements, regulator guidance and reputable secondary reporting current as of late September 2026. Laws change frequently. Always verify the current position with the relevant national authority before taking any action. CBDAfrica.com provides general informational content only and does not offer legal, medical or investment advice.
Understanding Cannabis, CBD, THC & Hemp Regulations in Africa
Africa consists of 54 sovereign countries. Cannabis (generally Cannabis sativa L. and related material containing controlled cannabinoids) is treated under national drug-control laws that implement the UN Single Convention on Narcotic Drugs (1961, as amended), the Convention on Psychotropic Substances (1971) and related instruments. National law, not continental or regional frameworks, determines legality.
THC (primarily Δ9-tetrahydrocannabinol) is the principal psychoactive cannabinoid. Concentration thresholds commonly distinguish industrial hemp from controlled cannabis, but thresholds, measurement methods (dry weight, flowering tops, finished products) and application to plant material versus extracts differ by country.
CBD (cannabidiol) is non-psychoactive. Its legal status is not uniform: some countries regulate it as a controlled substance when derived from cannabis, others permit low-THC CBD under medicines, food or cosmetics rules, and many lack specific CBD legislation, defaulting to general drug or medicines controls.
Industrial hemp is typically defined by a low THC threshold (commonly 0.2–1 %, occasionally higher) and intended for fibre, seed or industrial uses. Licensing, approved varieties and commercialisation rules vary.
Medical cannabis refers to authorised pharmaceutical or therapeutic use under prescription or special access, usually tightly controlled. Recreational / adult use means non-medical personal consumption. No African country has authorised commercial recreational retail markets as of this date. Decriminalisation or private-use protections (where they exist) do not create commercial markets.
Cannabis-derived products (oils, tinctures, edibles, beverages, cosmetics, topicals, pharmaceuticals, hemp foods/seed/fibre, vapes) are regulated by product category, intended use, THC/CBD content and source. Classification as a controlled drug, medicine, food or cosmetic determines the applicable rules.
How Cannabis Laws Differ Across Africa
Most countries maintain comprehensive prohibition of unauthorised possession, cultivation, sale and use, consistent with UN treaty obligations. A minority have enacted licensed frameworks focused on medical, scientific, industrial/hemp or export-oriented activity. Private adult use is constitutionally protected only in South Africa (with commercial sale remaining restricted). Decriminalisation is rare and limited. Information gaps persist in several jurisdictions; secondary sources and enforcement practice must be distinguished from enacted primary law.
CBD Regulations in Africa
CBD is rarely “legal” in an unrestricted sense. Status depends on source (hemp vs high-THC cannabis), THC residual content, product form, intended use and registration requirements. In progressive jurisdictions it may be permitted under medicines, cosmetics or industrial frameworks subject to licensing, testing and labelling. In the majority of countries it falls under general narcotic or medicines controls and is prohibited without authorisation. Imports require destination-country clearance regardless of origin-country legality.
THC Regulations in Africa
THC is controlled almost universally. Hemp thresholds in operational frameworks include:
- South Africa – 2 % (leaves and flowering heads, effective 1 December 2025 under the Plant Improvement Act 11 of 2018)
- Zimbabwe – 1 %
- Malawi – up to 1 % (or as prescribed)
- Ghana – 0.3 %
- Zambia – 0.3 %
- Botswana – 0.7 % (industrial cannabis)
Thresholds may apply to plant material, extracts or finished products and often differ for import/export. Exceeding the limit typically triggers controlled-substance rules.
Industrial Hemp Regulations in Africa
Licensed industrial hemp exists or is advancing in South Africa (Plant Improvement Act, 2 % THC, permits issued), Zimbabwe (SI 218/2019, 1 %), Malawi (Cannabis Regulation Act 2020), Ghana (Narcotics Control Commission Act, 0.3 %, first cultivation licences 2026), Zambia (Industrial Hemp Act 2021, commenced January 2025, 0.3 %), Uganda (Industrial Hemp Regulations 2020), Botswana (Cannabis Act 2025 + regulations), Lesotho, Morocco (Law 13-21) and others under medical/industrial licences. Requirements typically include cultivation licences, approved varieties/seeds, security, testing and export permits. Domestic consumer markets for hemp-derived products remain limited or closed in most cases.
Medical Cannabis Regulations in Africa
Licensed medical or scientific cultivation/production (often export-oriented) operates in Lesotho (first African licences ≈2017; 2025 amendments to fees and permits), Zimbabwe (SI 62/2018 + 2026 updates), Malawi, South Africa (SAHPRA s22C licences), Morocco (Law 13-21, ANRAC), Ghana, Uganda, Zambia, Rwanda (advancing commercial medical production 2026), Botswana and Eswatini (regulations exist but implementation limited). Patient access domestically is generally narrow or undeveloped; export is the primary focus. Regulators include medicines agencies, health ministries and specialised cannabis authorities.
Recreational Cannabis & Decriminalisation
No African country authorises commercial recreational sales. South Africa protects private adult possession, use and limited home cultivation (Cannabis for Private Purposes Act 2024; draft regulations published February 2026 propose quantity limits). Public use, sale and supply remain criminal. Elsewhere, recreational activity is prohibited. Limited tolerance or non-enforcement may occur informally in some areas but does not equate to legality.
Cannabis Cultivation & Licensing
Personal cultivation is protected only in South Africa (private purposes). Licensed commercial/medical/industrial cultivation requires site security, GACP/GMP standards, testing, tracking and specific licences from agriculture, health or specialised agencies. Unlicensed cultivation remains a serious offence almost everywhere.
CBD & Cannabis Products
Product rules diverge by category. Oils, edibles, cosmetics and supplements may be treated as medicines (prescription/registration), foods (novel-food or additive rules) or cosmetics (ingredient and claim restrictions). Residual THC, source material and marketing claims are decisive. Vapes and high-THC products face stricter controls. Hemp fibre and seed products are often less restricted once cultivation is licensed.
Importing & Exporting Cannabis, CBD & Hemp
Cross-border movement requires dual authorisation: export permit from the origin country and import permit from the destination, plus customs, phytosanitary and (for controlled substances) INCB-related documentation. Legality in the exporting country does not confer legality in the importing country. THC limits, product classification and laboratory certificates are critical. Pharmaceutical-grade material faces additional GMP and registration hurdles.
The 54 African Countries: Regulatory Overview
Master Country Table (concise status as of research date; “Unclear” indicates insufficient primary-source verification)
| Country | Recreational Cannabis | Medical Cannabis | Industrial Hemp | CBD | THC Regulation | Cultivation | Import/Export | Main Regulator | Last Verified |
|---|---|---|---|---|---|---|---|---|---|
| Algeria | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health/Drug authorities | 2026 |
| Angola | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Benin | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Botswana | Prohibited | Regulated (Cannabis Act 2025) | Regulated (0.7 %) | Under medical/industrial | 0.7 % industrial | Licensed | Licensed | Cannabis Control Authority / Health | Sep 2026 |
| Burkina Faso | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Burundi | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Cabo Verde | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Cameroon | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Central African Republic | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Chad | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Comoros | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| DR Congo | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Republic of the Congo | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Côte d’Ivoire | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Djibouti | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Egypt | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Equatorial Guinea | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Eritrea | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Eswatini | Prohibited | Limited (regulations exist) | Limited/unclear | Restricted | Controlled | Licensed possible | Restricted | Ministry of Health | 2026 |
| Ethiopia | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Gabon | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| The Gambia | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Ghana | Prohibited | Regulated (0.3 % THC) | Regulated (0.3 %) | Under licence | 0.3 % | Licensed (first licences 2026) | Licensed | NACOC | Sep 2026 |
| Guinea | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Guinea-Bissau | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Kenya | Prohibited | Limited/unclear | Limited/unclear | Restricted | Controlled | Restricted | Restricted | Health/Pharmacy authorities | 2026 |
| Lesotho | Prohibited | Regulated (export focus) | Possible under medical | Under licence | Controlled | Licensed (fees updated 2025) | Licensed | LeMeRA / LNB / Health | 2026 |
| Liberia | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Libya | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Madagascar | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Malawi | Prohibited | Regulated (Act 2020) | Regulated (≤1 %) | Under licence | ≤1 % or prescribed | Licensed | Licensed | Cannabis Regulatory Authority | 2026 |
| Mali | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Mauritania | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Mauritius | Prohibited | Limited/unclear | Limited/unclear | Restricted | Controlled | Restricted | Restricted | Health authorities | 2026 |
| Morocco | Prohibited | Regulated (Law 13-21) | Regulated | Under ANRAC | 1 % industrial | Licensed (designated provinces) | Licensed | ANRAC | 2026 |
| Mozambique | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Namibia | Prohibited | Limited/unclear | Limited/unclear | Restricted | Controlled | Restricted | Restricted | Health authorities | 2026 |
| Niger | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Nigeria | Prohibited | Limited/unclear | Limited/unclear | Restricted | Controlled | Restricted | Restricted | NAFDAC / NDLEA | 2026 |
| Rwanda | Prohibited | Advancing commercial medical | Possible | Under development | Controlled | Licensed planned | Export focus | Rwanda FDA / Health | Sep 2026 |
| São Tomé and Príncipe | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Senegal | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Seychelles | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Sierra Leone | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Somalia | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| South Africa | Private adult use protected; sale prohibited | Regulated (SAHPRA) | Regulated (≤2 % THC, Dec 2025) | Limited exemption (≤20 mg/day historically) | 2 % hemp; higher controlled | Private limited; commercial licensed | Licensed | SAHPRA / Agriculture / Justice | Sep 2026 |
| South Sudan | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Sudan | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Tanzania | Prohibited | Limited/unclear | Limited/unclear | Restricted | Controlled | Restricted | Restricted | Health authorities | 2026 |
| Togo | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Tunisia | Prohibited | Limited/unclear | Prohibited/unclear | Restricted | Controlled | Prohibited | Restricted | Health authorities | 2026 |
| Uganda | Prohibited | Licensed medical/export | Regulated (2020 regs) | Under licence | Controlled | Licensed | Licensed | NDA / Health / Agriculture | 2026 |
| Zambia | Prohibited | Regulated | Regulated (0.3 %, Act commenced 2025) | Under licence | 0.3 % hemp | Licensed | Licensed | ZAMRA / Agriculture / Health | 2026 |
| Zimbabwe | Prohibited | Regulated (SI 62/2018 + updates) | Regulated (≤1 %) | Under medical/industrial | ≤1 % hemp | Licensed | Licensed | MCAZ / Agriculture | 2026 |
Business / Regulatory Comparison Table (informational only – not an investment ranking)
| Country | Hemp Farming | Medical Cannabis Industry | CBD Products | Cannabis Cultivation | Export Framework | Licensing Framework |
|---|---|---|---|---|---|---|
| South Africa | Permitted under permit (2 % THC) | Established (SAHPRA) | Restricted/limited | Private + licensed medical | Operational | Multi-agency |
| Lesotho | Under medical licences | Established (export) | Under licence | Licensed | Operational | Updated 2025 fees |
| Zimbabwe | Licensed (1 %) | Established | Under medical/industrial | Licensed | Operational | MCAZ + Agriculture |
| Malawi | Licensed (≤1 %) | Established | Under licence | Licensed | Operational | Cannabis Regulatory Authority |
| Morocco | Licensed (designated areas) | Established (ANRAC) | Expanding (cosmetics etc.) | Licensed | Operational | ANRAC |
| Ghana | Licensed (0.3 %) | Emerging (first licences 2026) | Under licence | Licensed | Emerging | NACOC |
| Zambia | Licensed (0.3 %, commenced 2025) | Emerging | Under licence | Licensed | Emerging | Multi-agency |
| Uganda | Licensed | Emerging/experimental | Under licence | Licensed | Emerging | NDA etc. |
| Botswana | Regulated (0.7 %) | Emerging (2025 Act) | Under framework | Licensed | Emerging | New authority |
| Rwanda | Possible | Advancing (2026) | Developing | Planned licensed | Export focus | FDA / Health |
| Others | Generally prohibited or unclear | Limited or none | Restricted | Prohibited/unlicensed | Restricted | Strict drug-control |
African Cannabis & Hemp Regulatory Patterns
- Medical/export-oriented frameworks are concentrated in Southern and parts of East/West Africa (Lesotho, Zimbabwe, Malawi, South Africa, Morocco, Ghana, Zambia, Uganda, Botswana, Rwanda advancing).
- Industrial hemp programmes are expanding with varying THC thresholds (highest operational in South Africa at 2 %).
- Export industries exist where licensing and international compliance (testing, tracking) are mature.
- Private adult-use protection is unique to South Africa.
- The large majority of countries maintain full prohibition aligned with UN conventions; public information is often limited.
- Legislation continues to evolve (South Africa Cannabis Bill targeted mid-2027; multiple 2025–2026 commencement and fee updates).
African Cannabis Regulatory Timeline
- 2017–2018 – Lesotho issues first African medical cannabis licences; Zimbabwe SI 62/2018 medical production.
- 2020 – Malawi Cannabis Regulation Act; Uganda Industrial Hemp Regulations.
- 2021 – Morocco Law 13-21; Zambia Cannabis & Industrial Hemp Acts enacted (hemp commenced 2025).
- 2024 – South Africa Cannabis for Private Purposes Act; Ghana/NACOC regulatory progress.
- 2025 – South Africa Plant Improvement Act (hemp 2 % THC, 1 Dec); Lesotho Cannabis Regulations Amendment (fees/permits); Botswana Cannabis Act; Zambia Industrial Hemp Act commencement; Ghana first cultivation licences process.
- 2026 – South Africa draft private-use regulations (Feb); Botswana regulations and narcotics amendments; Ghana first cultivation licences issued; Rwanda advancing commercial medical production; multiple fee and implementation updates.
What Consumers Need to Know
Verify product origin, THC content, registration status and local law before purchase or use. CBD products sold online or informally may still be controlled. Cross-border transport risks severe penalties.
What Businesses Need to Know
Confirm product classification, THC threshold, required licences (cultivation, manufacture, processing, sale), testing, labelling, advertising restrictions and tax rules. Destination-country import rules govern exports.
What Farmers Need to Know
Obtain the correct cultivation licence, use approved seed/varieties, meet security and GACP standards, and test for THC compliance. Unlicensed cultivation remains criminal in virtually all jurisdictions.
What Importers & Exporters Need to Know
Secure dual permits, phytosanitary certificates, laboratory analysis and compliance with both origin and destination controlled-substance and customs rules. Legality is not portable across borders.
How to Verify Cannabis Laws in Africa
- Consult the national gazette or official legislation portal.
- Contact the medicines regulator, agriculture ministry or specialised cannabis authority.
- Review INCB and UNODC country reports for international context.
- Seek qualified local legal counsel for commercial or personal decisions.
- Treat secondary news and company claims as leads, not definitive authority.
Frequently Asked Questions
Is cannabis legal in Africa?
No single answer. Most countries prohibit it; a minority permit licensed medical/industrial activity; South Africa protects private adult use.
Is CBD legal in Africa?
Varies by country, source, THC content and product type. Rarely unrestricted.
Is THC legal in Africa?
Controlled almost everywhere; low-THC thresholds apply only to licensed hemp where frameworks exist.
Which African countries allow medical cannabis?
Licensed frameworks operate or are advancing in Lesotho, Zimbabwe, Malawi, South Africa, Morocco, Ghana, Zambia, Uganda, Botswana, Rwanda and limited others.
Which African countries allow industrial hemp?
South Africa, Zimbabwe, Malawi, Ghana, Zambia, Uganda, Botswana, Morocco and others under licence.
Can you grow hemp in Africa?
Only under licence in countries with operational frameworks; unlicensed growth is prohibited.
Can you legally sell CBD in Africa?
Only where product-specific authorisation exists; most markets remain closed or heavily restricted.
Can CBD products be imported into Africa?
Subject to destination-country import permits and classification rules.
Can cannabis be exported from Africa?
Yes from licensed producers in operational jurisdictions, subject to dual authorisation.
What is the difference between hemp and cannabis?
Primarily THC concentration and intended use; legal definitions are country-specific.
What is the legal THC limit for hemp?
Country-specific: e.g. South Africa 2 %, Zimbabwe 1 %, Ghana/Zambia 0.3 %.
Is medical cannabis the same as recreational cannabis?
No. Medical frameworks do not authorise recreational use or sale.
What does cannabis decriminalisation mean?
Reduction or removal of criminal penalties for certain conduct without creating a legal market. Rare in Africa.
Are CBD oils legal in Africa?
Depends on jurisdiction, THC residual, registration and intended use.
Are CBD foods legal in Africa?
Generally subject to food and novel-food rules; often restricted.
Are CBD cosmetics legal in Africa?
Possible under cosmetics rules in some licensed frameworks (e.g. Morocco developments).
Can farmers grow industrial hemp?
Only with the required licence and compliance in permitting countries.
How are cannabis businesses licensed?
Multi-agency processes involving health, agriculture and specialised regulators; requirements include security, testing and tracking.
Which authorities regulate cannabis?
Medicines agencies (SAHPRA, MCAZ, NDA, ANRAC, NACOC, etc.), agriculture ministries and drug-control bodies.
Where can I find official cannabis legislation?
National government gazettes, regulator websites and parliamentary portals. Cross-check commencement status.
CBDAfrica.com Regulatory Resources
Future resources recommended: interactive regulatory map, CBD/hemp/THC databases, medical-cannabis tracker, licence tracker, legislation library, and country/regional guides (priority: South Africa, Lesotho, Zimbabwe, Uganda, Ghana, Nigeria, Kenya, Morocco). Each entry should record source, type, dates, confidence and last-checked status. Regional guides and individual country pages should link back to this overview.
Medical disclaimer: CBD and cannabis-related health information is for general educational purposes only and does not constitute medical advice. Consult qualified healthcare professionals regarding medical conditions, medicines, potential interactions and treatment decisions.
Legal disclaimer: Cannabis, CBD, THC and hemp laws vary by country and can change. CBDAfrica.com provides general informational content and does not provide legal advice. Readers, businesses, farmers and organisations should verify current requirements with the relevant government authority or qualified legal professional before taking any action.
This document is intended as a reliable starting point for the CBDAfrica.com African Cannabis, CBD, THC & Hemp Regulatory Database. Confidence is high for South Africa, Lesotho, Zimbabwe, Malawi, Morocco, Ghana, Zambia, Botswana and Uganda where primary or near-primary sources were located; medium-to-low for jurisdictions with sparse public primary documentation. Updates will be required as laws evolve.